Form 4 for RNTX Rein Therapeutics, Inc.
Accepted 2023-12-18 00:00:00 ET · period of report 2023-12-15 · accession 0000950170-23-071200 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2023-12-18 | 2023-12-15 | RNTX | WINDSOR JAMES BRIAN | Pres, COO | P - Purchase | $3.37 | +225 | 225 | New | +$758.25 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-12-15 | P | A | 225 | $3.37 | 225 | I By son | — | — | (F1) The reporting person disclaims beneficial ownership of all securities held by his son, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose |